Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patients.
cancer
depression
oncology
ovarian neoplasms
psycho-oncology
psychological
psychosocial functioning
quality of life
sleep
stress
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
02
03
2021
received:
21
12
2020
accepted:
12
03
2021
pubmed:
25
3
2021
medline:
16
4
2022
entrez:
24
3
2021
Statut:
ppublish
Résumé
Ovarian cancer is characterized by poor prognosis, high levels of distress, disturbed sleep, and compromised quality of life (QOL). Although life stressors have been shown to significantly impact physical and psychological health in cancer populations, no studies have used a high-resolution stress assessment to differentiate effects of acute versus chronic stressors among women with ovarian cancer. We addressed this issue in the present prospective longitudinal study by examining how acute and chronic stress exposure in the year pre-diagnosis relate to depressive symptoms, sleep quality, and QOL over the first year post-diagnosis in women with ovarian cancer. One hundred thirty-seven women completed the Life Events and Difficulties Schedule within a month of initial treatment for suspected ovarian cancer. Depressive symptoms, sleep, and QOL were measured pre-treatment, at six months, and one-year post-diagnosis. Mixed models were used to examine associations of acute and chronic stress pre-diagnosis with (a) change in psychosocial outcomes over the first year post-diagnosis and (b) levels of psychosocial outcomes across all time points. Both the number and severity of chronic difficulties (but not acute life events) were related to significantly greater depression, and poorer sleep quality and QOL, across all time-points. In contrast, these stress indices were unrelated to changes in psychosocial functioning over time. Chronic but not acute stress exposure predicted average levels of depression, sleep, and QOL in the first year post-diagnosis among women with ovarian cancer. Assessing stressors and designing interventions for reducing stress may thus be beneficial for ovarian cancer patients.
Identifiants
pubmed: 33760306
doi: 10.1002/pon.5682
pmc: PMC8178235
mid: NIHMS1696253
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
954-961Subventions
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NIMH NIH HHS
ID : K08 MH103443
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA140933
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193249
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA246540
Pays : United States
Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
J Clin Oncol. 2001 Mar 15;19(6):1809-17
pubmed: 11251013
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Holist Nurs Pract. 2003 Nov-Dec;17(6):300-8
pubmed: 14650572
Brain Behav Immun. 2019 Jan;75:3-5
pubmed: 30236597
Cancer. 2003 Sep 1;98(5):1061-71
pubmed: 12942576
Support Care Cancer. 2008 Nov;16(11):1231-41
pubmed: 18386077
Front Neuroendocrinol. 2018 Apr;49:146-169
pubmed: 29551356
Aust N Z J Psychiatry. 2002 Apr;36(2):173-82
pubmed: 11982537
Soc Psychiatry Psychiatr Epidemiol. 2003 Aug;38(8):442-9
pubmed: 12910340
Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1183-93
pubmed: 18217977
Cancer Res. 2019 Jun 28;:
pubmed: 31253667
Psychosom Med. 2003 Mar-Apr;65(2):259-67
pubmed: 12651993
Psychooncology. 2004 Mar;13(3):211-20
pubmed: 15022156
Cancer. 2013 Sep 1;119(17):3234-41
pubmed: 23797955
Psychol Med. 1978 Nov;8(4):577-88
pubmed: 724871
J Health Psychol. 2016 Jun;21(6):1004-14
pubmed: 25139892
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer. 2015 Jun 1;121(11):1873-81
pubmed: 25809235
Am J Psychiatry. 1999 Jun;156(6):837-41
pubmed: 10360120
Arch Gen Psychiatry. 2012 Jun;69(6):618-26
pubmed: 22664550
Annu Rev Clin Psychol. 2008;4:33-52
pubmed: 17716038
Gynecol Oncol. 2013 Dec;131(3):667-73
pubmed: 24096110
Cancer. 2012 Aug 1;118(15):3766-75
pubmed: 22180393
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Health Qual Life Outcomes. 2003 Dec 16;1:79
pubmed: 14678568
J Clin Oncol. 2012 Apr 10;30(11):1160-77
pubmed: 22412146
Psychoneuroendocrinology. 2017 Oct;84:139-142
pubmed: 28711723
Int J Behav Med. 2005;12(4):278-85
pubmed: 16262547
Annu Rev Clin Psychol. 2005;1:293-319
pubmed: 17716090
Psychosom Med. 2018 Jan;80(1):17-27
pubmed: 29016550
Psychosom Med. 2000 Mar-Apr;62(2):227-30
pubmed: 10772402
Clin Psychol Sci. 2014 Jan;2(1):
pubmed: 24377083
Brain Behav Immun. 2013 Mar;30 Suppl:S19-25
pubmed: 22728325
J Abnorm Psychol. 2010 Nov;119(4):791-803
pubmed: 20853920
Stat Med. 2000 Jul 15;19(13):1793-819
pubmed: 10861779
Ann N Y Acad Sci. 2004 Dec;1032:1-7
pubmed: 15677391
Exp Neurol. 2012 Jan;233(1):102-11
pubmed: 22101006